π¨ NOW OPEN: Pre-Application for Rare Kidney Disease/Glomerular Disease Centers of Excellence! π¨
Join exceptional institutions, clinics, and healthcare organizations to become designated Centers of Excellence.
π― What you'll gain:
β Access to premier fellowship programs
β Secure database platform for operational and research registry
β Exclusive director network meetings
β Free conference registration + educational resources
β Clinical trial support services
β Population health dashboards
π₯ Perfect for:
β’ Academic medical centers
β’ Nephrology Clinics
β’ Healthcare institutions serving rare kidney disease populations
π Timeline: Pre-applications open NOW | Framework release Fall 2025
Ready to elevate your rare kidney disease program? Apply today! π
https://t.co/jtjIODkINM
#RareKidneyDisease #GlomerularDisease #CentersOfExcellence #Nephrology #PatientCare
Who actually benefits from plasmapheresis? Amber Sanchez leads a two-part series of pheresis clinical workshop sessions.
Part 1 focuses on the practical, bedside engineering of vascular access, replacement fluids, and circuit safety. Part 2 tackles the PEXIVAS paradox in ANCA vasculitis, post-transplant FSGS recurrence, and evidence-based indications. #Plasmapheresis #Nephrology #GlomConHawaii2026 #ClinicalEvidence
Join GlomCon this Sunday
B and Plasma Cell-Targeting Therapies for Podocytopathies by Dr. Andrea Angeletti
ID: 817 4374 4653
Passcode: 202122
Sign up π https://t.co/fxh2CVuWhy
#GlomCon
Day 1 of the 49th Annual Columbia Renal Biopsy Course is packed with foundational and cutting-edge content! From Histopathology of the Glomerulus to current therapy of MCD & FSGS, Membranous Nephropathy updates, and C3G β this is where the latest in glomerular disease meets practical biopsy interpretation.
Join us in NYC or virtually https://t.co/wHpFUYW4FR
#RenalBiopsy #Nephrology #CME @AgnesFogo@ColumbiaMed @ColumbiaKidney @glomcon
Deadline approaching: Submit your abstract to GlomCon Hawaii 2026 by June 10 π’
Accepted submissions will be notified by June 22 and may be featured as oral or poster presentations.
Learn more π https://t.co/0xaMCf0LFa
#GlomConHawaii#GlomCon
π’ The Rare Disease And Nephrology Research Training (RADIANT) Program is now accepting applications!
RADIANT Program is designed to teach foundational knowledge and skills in rare kidney disease research with a focus on clinical research in glomerular diseases.
Applications close on June 24.
πFor more information, visit us at https://t.co/gxN0z95R6l
#GlomCon #RADIANTProgram #education #research #training #nephrology #clinicalresearch
AI feedback vs. human feedback >> we put it to the test βοΈ
At @GlomCon Fellowship, we care about how we teach, not just what we teach. So we studied one of the most overlooked skills: giving great feedback.
See the details hereπ
https://t.co/xi4GRwsMwH
@GlomCon@poyanmehr I highly recommend if you can fit it your schedule. Many trainees donβt get enough exposure during fellowship to feel comfortable with GN diagnosis and management . Great to hear from the global experts in a field with rapidly changing therapeutics.
From trial efficacy to real-world effectiveness: @DanaRizk1 , Dustin Little, @jardine_meg , @Suceena , @willkidney , and Michael Walsh are leading a session on the design and future of Phase IV trials and registry-driven evidence in IgA nephropathy.
#IgAN#PhaseIV #RealWorldEvidence #GlomConHawaii2026 #Methodology
π’ The GlomCon Glomerular Disease Fellowship is now accepting applications!
Make sure you don't miss out on the chance to apply for the program, learn from top experts in the field, and engage in interactive workshops with them.
Join the GlomCon family by applying today!
π Learn more: https://t.co/7XIfdsZrzq
@SaynaNorouzi@nephrologista@BetterCallSeeth
#GlomCon #glomconfellowship #GlomerularDisease #nephrology
From trial efficacy to real-world effectiveness: @DanaRizk1 , Dustin Little, @jardine_meg , @Suceena , @willkidney , and Michael Walsh are leading a session on the design and future of Phase IV trials and registry-driven evidence in IgA nephropathy.
#IgAN#PhaseIV #RealWorldEvidence #GlomConHawaii2026 #Methodology
π’ The GlomCon Glomerular Disease Fellowship is now accepting applications!
Make sure you don't miss out on the chance to apply for the program, learn from top experts in the field, and engage in interactive workshops with them.
Join the GlomCon family by applying today!
π Learn more: https://t.co/7XIfdsZrzq
@SaynaNorouzi@nephrologista@BetterCallSeeth
#GlomCon #glomconfellowship #GlomerularDisease #nephrology
How do we design clinical trials for a disease as heterogeneous as FSGS?
@PolskiBarbara, @PRomagnani , Ingeborg Bajema, Mohit Mathur, Dustin Little, Michael Walsh discuss endpoints, comparators, and biomarker enrichment.
#FSGS#ClinicalTrials#GlomConHawaii2026 #TrialMethodology